Literature DB >> 2158038

Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family.

M Shibuya1, S Yamaguchi, A Yamane, T Ikeda, A Tojo, H Matsushime, M Sato.   

Abstract

A new human gene encoding a receptor-type tyrosine kinase was isolated by a weak cross-hybridization with v-ros oncogene. A cDNA of about 7.7 kb carried a 4.2 kb open reading frame, and the predicted amino acid sequence of 1338 residues contained extracellular, transmembrane and tyrosine kinase domains. Although its extracellular domain is approximately 220 amino acids longer than those of the products of the fms family, i.e. c-fms, c-kit and platelet-derived growth factor receptor genes, the overall structure including cysteine motifs in its extracellular domain and a long peptide insertion in its tyrosine kinase domain indicates that this new gene is closely related to the fms family. Consequently, the gene was designated as flt (fms-like tyrosine kinase) gene. The expression of the flt gene was strongly suppressed in most of the tumor cell lines examined so far, whereas this mRNA was expressed in a variety of normal tissues of adult rat.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2158038

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  162 in total

1.  Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5' nuclease quantitative reverse transcription-polymerase chain reaction.

Authors:  T E Godfrey; S H Kim; M Chavira; D W Ruff; R S Warren; J W Gray; R H Jensen
Journal:  J Mol Diagn       Date:  2000-05       Impact factor: 5.568

2.  In silico cloning of novel endothelial-specific genes.

Authors:  L Huminiecki; R Bicknell
Journal:  Genome Res       Date:  2000-11       Impact factor: 9.043

3.  A genomewide survey of developmentally relevant genes in Ciona intestinalis. V. Genes for receptor tyrosine kinase pathway and Notch signaling pathway.

Authors:  Yutaka Satou; Yasunori Sasakura; Lixy Yamada; Kaoru S Imai; Nori Satoh; Bernard Degnan
Journal:  Dev Genes Evol       Date:  2003-05-09       Impact factor: 0.900

4.  RYK, a receptor tyrosine kinase-related molecule with unusual kinase domain motifs.

Authors:  C M Hovens; S A Stacker; A C Andres; A G Harpur; A Ziemiecki; A F Wilks
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

5.  Dinucleotide repeat polymorphism at the human fms-related tyrosine kinase gene (FLT1).

Authors:  M H Polymeropoulos; D S Rath; H Xiao; C R Merril
Journal:  Nucleic Acids Res       Date:  1991-05-25       Impact factor: 16.971

6.  Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy.

Authors:  Napoleone Ferrara
Journal:  Nat Med       Date:  2010-10       Impact factor: 53.440

7.  ETS-1 protein regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell line SKOV-3.

Authors:  Sonali Ghosh; Moitri Basu; Sib Sankar Roy
Journal:  J Biol Chem       Date:  2012-01-23       Impact factor: 5.157

Review 8.  Cardiovascular genomics: a current overview of in vivo and in vitro studies.

Authors:  Devi Mariappan; Johannes Winkler; Jürgen Hescheler; Agapios Sachinidis
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

9.  Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin.

Authors:  G D'Angelo; I Struman; J Martial; R I Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

10.  Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide.

Authors:  R M Tuder; B E Flook; N F Voelkel
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.